株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

RNA干渉 (RNAi) 技術市場の予測:用途別 (研究開発、治療法、創薬、農業) 、ツール別 (設計/ソフトウェア、提供ベース、モニタリング、図書館) 、地域別

Ribonucleic Acid Interference (RNAi) Technology Market: By Application (Research and Development, Therapeutics, Drug Discovery, Agriculture), By Tools (Design/Software, Delivery Based, Monitoring, Libraries) & By Region-Forecast (2016-2021)

発行 IndustryARC 商品コード 422491
出版日 ページ情報 英文 132 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.53円で換算しております。
Back to Top
RNA干渉 (RNAi) 技術市場の予測:用途別 (研究開発、治療法、創薬、農業) 、ツール別 (設計/ソフトウェア、提供ベース、モニタリング、図書館) 、地域別 Ribonucleic Acid Interference (RNAi) Technology Market: By Application (Research and Development, Therapeutics, Drug Discovery, Agriculture), By Tools (Design/Software, Delivery Based, Monitoring, Libraries) & By Region-Forecast (2016-2021)
出版日: 2016年10月06日 ページ情報: 英文 132 Pages
概要

当レポートでは、世界のRNA干渉 (RNAi) 技術市場について調査分析し、市場情勢、市場力学、戦略的分析、市場分析 (セグメント別) のほか、主要企業などについて、体系的な情報を提供しています。

第1章 RNA干渉 (RNAi) 技術:市場概要

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場シェア分析
  • 比較分析
  • 製品ベンチマーキング
  • エンドユーザープロファイリング
  • 5大財務分析

第4章 RNA干渉 (RNAi) 技術:市場力学

  • 市場促進要因
  • 市場抑制要因
  • 市場の機会
  • 市場の課題
  • ファイブフォース分析

第5章 RNA干渉 (RNAi) 技術市場:戦略的分析

  • バリューチェーン分析
  • 価格分析
  • 機会分析
  • 製品/市場ライフサイクル分析
  • サプライヤー・販売業者

第6章 RNA干渉 (RNAi) 技術市場:ツール別

  • 設計/ソフトウェア
  • 提供ベース
  • モニタリング
  • 図書館
  • その他

第7章 RNA干渉 (RNAi) 技術市場:用途別

  • 研究開発
  • 治療法
  • 創薬
  • 農業
  • その他

第8章 RNA干渉 (RNAi) 技術市場:地域別

  • 欧州
  • アジア太平洋地域
  • 北米
  • その他

第9章 RNA干渉 (RNAi) 技術市場:市場エントロピー

  • 事業拡大
  • 技術開発
  • 新製品発売
  • M&A、合弁事業
  • 供給契約

第10章 企業プロファイル

  • Rosetta Genomics
  • Exiqon A/S
  • Merck KGaA
  • Pfizer Inc.
  • F. Hoffmann-La Roche AG
  • Alnylam pharmaceuticals
  • Arrowhead research corporation
  • Quark pharmaceuticals inc
  • Rxi pharmaceuticals corp.
  • Silence therapeutics
  • Tekmira pharmaceuticals corp
  • Thermo fisher scientific inc

第11章 付録

目次

RNAi (Ribonucleic Acid Interference) a system in live cells to keep a check on the active genes is the next promising technology in the field of biotechnology. The major classes of RNAi are micro RNA and small interfering RNA. RNAi is said to be the replacement technology for the existing recombinant technology in the field of drug discovery and therapeutics. Globally increasing R&D activities in the field of RNAi activities is expected to be the key growth driver during the period of study.

Geographically North America dominated RNAi technology market owing to the large scale of its pharmaceutical industry which invests heavily in R&D activities to formulate and update new therapies. North America was followed by Europe and Asia-Pacific as second and third largest market for RNAi technology market. Asia Pacific is projected to have fastest growth, owing to rapidly increasing pharmaceutical industrial infrastructure which has attracted many global industry player, government initiatives and in developing nations such as China, and India in this region.

This report identifies the global RNAi technology market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global RNAi technology market.

This report segments global RNAi technology market on the basis of application, tools and regional market as follows:

RNAi Technology Market research report is classified on the basis of applications of RNAi technology in wide range of industries some of the major applications of RNAi Technology covered in this report are as follows: Research and Development, Therapeutics, Drug Discovery, Agriculture and Others

RNAi technology market research report is classified on the basis of tools of RNAi technology in wide range of industries some of the major applications of RNAi technology covered in this report are as follows: Design/Software, Delivery Based, Monitoring, Libraries

This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the RNAi technology market. Some of the major companies' profiles in detail are as follows:

F. Hoffmann-La Roche AG

Alnylam pharmaceuticals

Arrowhead research corporation

Quark pharmaceuticals inc

Rxi pharmaceuticals corp.

Table of Contents

1. RNAi Technology Market - Market Overview

2. Executive Summary

3. Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
  • 3.3. Product Benchmarking
  • 3.4. End User Profiling
  • 3.5. Top 5 Financials Analysis

4. RNAi Technology Market- Market Forces

  • 4.1. Drivers
    • 4.1.1. Increasing R&D activities in the field of RNAi
  • 4.2. Restraints
  • 4.3. Opportunities
  • 4.4. Challenges
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Buyers
    • 4.5.3. Threat of New Entrants
    • 4.5.4. Threat of Substitutes
    • 4.5.5. Degree of Competition

5. RNAi Technology Market- Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Opportunities Analysis
  • 5.4. Product/Market Life Cycle Analysis
  • 5.5. Suppliers and Distributors

6. RNAi Technology Market, By Tools

  • 6.1. Design/Software
  • 6.2. Delivery Based
  • 6.3. Monitoring
  • 6.4. Libraries
  • 6.5. Others

7. RNAi Technology Market, By Applications

  • 7.1. Research and Development
  • 7.2. Therapeutics
  • 7.3. Drug Discovery
  • 7.4. Agriculture
  • 7.5. Others

8. RNAi Technology Market, By Geography

  • 8.1. Europe
    • 8.1.1. Germany
    • 8.1.2. France
    • 8.1.3. Italy
    • 8.1.4. Spain
    • 8.1.5. Russia
    • 8.1.6. U.K.
    • 8.1.7. Rest of Europe
  • 8.2. Asia Pacific
    • 8.2.1. China
    • 8.2.2. India
    • 8.2.3. Japan
    • 8.2.4. South Korea
    • 8.2.5. Rest of Asia-Pacific
  • 8.3. North America
    • 8.3.1. U.S.
    • 8.3.2. Canada
    • 8.3.3. Mexico
  • 8.4. Rest of the World (RoW)
    • 8.4.1. Brazil
    • 8.4.2. Rest of RoW

9. RNAi Technology Market - Market Entropy

  • 9.1. Expansion
  • 9.2. Technological Developments
  • 9.3. Merger & Acquisitions, and Joint Ventures
  • 9.4. Supply- Contract

10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

  • 10.1. Rosetta Genomics
  • 10.2. Exiqon A/S
  • 10.3. Merck KGaA
  • 10.4. Pfizer Inc.
  • 10.5. F. Hoffmann-La Roche AG
  • 10.6. Alnylam pharmaceuticals
  • 10.7. Arrowhead research corporation
  • 10.8. Quark pharmaceuticals inc
  • 10.9. Rxi pharmaceuticals corp.
  • 10.10. Silence therapeutics
  • 10.11. Tekmira pharmaceuticals corp
  • 10.12. Thermo fisher scientific inc

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

11. Appendix

  • 11.1. Abbreviations
  • 11.2. Sources
  • 11.3. Research Methodology
  • 11.4. Bibliography
  • 11.5. Compilation of Expert Insights
  • 11.6. Disclaimer
Back to Top